← Leaderboards
Gustavo F. Doncel
Eastern Virginia Medical School
$4,039,056
Attributed
$5,735,922
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,735,922 · 3
By mechanism
R01$5,735,922 · 3
Top collaborators
- Meredith R Clark3 shared
- Thanh Nguyen2 shared
Most similar at Eastern Virginia Medical School
Same institution · by research overlap
- David Archer$1,976,191
- Meredith R Clark$8,131,519
- Terry Ann Jacot$398,196
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoPreventionDrug KineticsIn VitroInfectionPharmacodynamicsTransmission ProcessInnovationTissuesPreventProphylactic TreatmentWomanSuccessHiv InfectionsGenital SystemVaginaTenofovirMicrobicideFemaleVaginal GelStagingScreeningStructureSampling
Grant awards (10)
Advancing Multi-bNAbs Microneedle Patch Technology For HIV-1 Prevention in Breastfeeding Infants.$789,773
R01 · FY2025 · AI · contact PI
Advancing Multi-bNAbs Microneedle Patch Technology For HIV-1 Prevention in Breastfeeding Infants.$807,257
R01 · FY2024 · AI · contact PI
Novel long-acting microbicide and contraceptive intrauterine system$582,848
R01 · FY2017 · AI · contact PI
Novel long-acting microbicide and contraceptive intrauterine system$631,950
R01 · FY2016 · AI · contact PI
Differential HIV infection and tenofovir activity in pre and postmenopausal women$455,709
R01 · FY2016 · HD · contact PI
Novel long-acting microbicide and contraceptive intrauterine system$581,904
R01 · FY2015 · AI · contact PI
Differential HIV infection and tenofovir activity in pre and postmenopausal women$471,604
R01 · FY2015 · HD · contact PI
Differential HIV infection and tenofovir activity in pre and postmenopausal women$457,533
R01 · FY2014 · HD · contact PI
Differential HIV infection and tenofovir activity in pre and postmenopausal women$463,596
R01 · FY2013 · HD · contact PI
Differential HIV infection and tenofovir activity in pre and postmenopausal women$493,748
R01 · FY2012 · HD · contact PI